[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K/A CURRENT REPORT June 10, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation Indentification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Item 4 –]
[Form 6-K TABLE OF CONTENTS Page 3 4]
[Form 6-K TABLE OF CONTENTS Page 3 4]
[TPI Board Reinstates Stock Repurchase Program Friday June 3, 2011, 8:02 am EDT Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today announced that the Board of Directors has reinstated the stock repurchase program that authorized the repurchase of up to 3 million] []
[TPI Board Reinstates Stock Repurchase Program Friday June 3, 2011, 8:02 am EDT Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today announced that the Board of Directors has reinstated the stock repurchase program that authorized the repurchase of up to 3 million] []
[FORM OF RESTRICTED SHARE AWARD AGREEMENT 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC. * * * * * Participant: _______ Number of Restricted Shares granted: _______ * * * * * 1. Incorporation By Reference; Plan Document Receipt . 2. Grant of Restricted Share Award . Vesting 3.1 · _______________________________________ 3.2 3.3 If the Participant’s employment with the] [FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC * * * * * Optionee: ________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ * * * * * 1. Incorporation By Reference; Plan Document Receipt . 2. Grant of Option . 3. No Dividends Equivalents . 4.] [EMPLOYMENT AGREEMENT 聘用协议 May 31 Agreement Company nd Employee ### ## #### Parties This EMPLOYMENT AGREEMENT is made and entered into on — 17 2 570216 ### ## #### 2011-5- 31. 这份协议是由中国医药控股有限公司（“公司”） WITNESSETH: 条款 WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and 鉴于，公司是一家在中国从事研发，生产，销售的专业的制药企业。并且 WHEREAS, Employee has represented]
